Latest Mergers And Acquisitions News

The Federal Court has approved the acquisition scheme for Insignia Financial by CC Capital Partners, setting the stage for a $4.80 per share cash payout and imminent ASX suspension.

Great Divide Mining’s joint venture partner Dart Mining confirms broad, shallow gold mineralisation at the Banshee Prospect, highlighting potential underestimation in historic drilling and advancing resource definition efforts.

Taiton Resources has raised $1.25 million through a discounted placement to accelerate drilling at its Highway Copper-Gold Project, including immediate work on the high-priority Yogi IOCG target, alongside exploration at Challenger West and technical studies at Kingsgate.

Predictive Discovery and Robex Resources have completed all merger steps except the final administrative confirmation from Quebec, bringing the combined West African gold producer closer to operational integration.

Horizon Oil has crossed the crucial 50.1% acceptance threshold in its off-market bid for Cue Energy, removing a key condition from the offer. Meanwhile, the Mereenie joint venture suspends planned drilling after gas sales talks with Northern Territory’s Power and Water Corporation expire.

Connexion Mobility reported a record $3 million quarterly revenue, boosted by exclusive software deployment for GM Canada’s Enhanced Exposure Program, while net profit before tax fell 31% due to higher expenses.

Dart Mining NL has confirmed broadening gold mineralisation at its Coonambula project in Central Queensland, with recent diamond drilling assays revealing promising shallow intercepts that could reshape the economic potential of the Banshee prospect.

Hawk Resources has reported high-grade copper mineralisation near surface at its Cactus project in Utah, with spot pXRF assays peaking at 37.3% copper over potentially wide intervals. The ongoing drilling campaign aims to delineate a shallow mineralised zone along a historically mined corridor.

Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.

BlinkLab has secured A$17.5 million through an oversubscribed placement to fuel regulatory trials and commercial launch of its AI-driven autism and ADHD diagnostic tools.

Western Mines Group has streamlined its exploration portfolio by divesting non-core tenements and acquiring two promising greenfield nickel-copper sulphide projects along the Yilgarn Craton margins, aligning with its magmatic sulphide expertise.

Xenitra Limited’s Q3 sales soared to $8.3 million, a 300% jump over Q2, driven by its Nutritionals division and a strategic $30 million partnership with Rockcheck Group for Danone products. The company also launched new OTC medicines and blockchain tokenised sales channels poised to fuel future growth.